本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ORUKA THERAPEUTICS INC

39.68
-0.3200-0.80%
成交量:32.65萬
成交額:1,329.21萬
市值:19.66億
市盈率:-18.65
高:42.41
開:41.28
低:39.20
收:40.00
52周最高:42.41
52周最低:5.49
股本:4,954.27萬
流通股本:3,420.59萬
量比:2.35
換手率:0.95%
股息:- -
股息率:- -
每股收益(TTM):-2.1281
每股收益(LYR):-4.2259
淨資產收益率:-24.69%
總資產收益率:-17.25%
市淨率:4.19
市盈率(LYR):-9.39

資料載入中...

2026/03/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/11

重要事件披露

Form 8-K - Current report
2025/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/09/22

重要事件披露

Form 8-K - Current report
2025/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/01

重要事件披露

Form 8-K - Current report
2025/06/03

重要事件披露

Form 8-K - Current report
2025/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/03/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/06

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/05

重要事件披露

Form 8-K - Current report
2024/12/19

重要事件披露

Form 8-K - Current report
2024/11/22

SEC問詢函

Form CORRESP - Correspondence
2024/11/21

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/19

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]